Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study.
Journal: Journal for immunotherapy of cancer
Published: February 23, 2026
Real-world treatment patterns in stage III and IV melanoma patients: insights from a global multi-center chart review study.
Journal: Frontiers in immunology
Published: February 18, 2026
Phase I/II clinical trial of a melanoma vaccine targeting shared non-mutated antigens and a shared mutated BRAF neoantigen with an agonistic CD40 antibody (CDX-1140) plus TLR3 agonist (poly-ICLC).
Journal: Journal for immunotherapy of cancer
Published: February 09, 2026
Priorities for local immunotherapy research and drug development.
Journal: Journal for immunotherapy of cancer
Published: January 31, 2026
Treatment effect of neoadjuvant immunotherapy in melanoma correlates with tumor burden: meta-analysis of reported clinical trials.
Journal: Melanoma research
Published: October 13, 2025
Genetic Landscape of Mucosal Melanoma: Identifying Pathogenic Germline Variants.
Journal: Pigment cell & melanoma research
Published: January 06, 2025
Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): safety, efficacy, and exploratory biomarker analysis.
Journal: Journal for immunotherapy of cancer
Published: December 29, 2024
Orthogonal CRISPR screens to identify transcriptional and epigenetic regulators of human CD8 T cell function.
Journal: bioRxiv : the preprint server for biology
Published: May 19, 2023
Real-world outcomes of patients with resected stage III melanoma treated with adjuvant therapies.
Journal: Cancer medicine
Published: March 21, 2023
Last Updated: 09/26/2026